Results 191 to 200 of about 376,341 (357)

Diastolic and autonomous dysfunction linked to heterogeneous myocardial repolarization and arrhythmia risk in patients with arterial hypertension and left ventricular hypertrophy

, 2017
A. P. Ivanov, E. A. Sayeda, I. A. Elgardt, N. S. Sdobnyakova   +3 more
openalex   +2 more sources

Age‐related differences in hydroxychloroquine‐associated adverse events: A pharmacovigilance study based on the FDA Adverse Event Reporting System

British Journal of Clinical Pharmacology, EarlyView.
Aims This real‐world pharmacovigilance study utilizes FDA Adverse Event Reporting System (FAERS) data (2004–2024) to characterize age‐related disparities in hydroxychloroquine (HCQ)‐associated adverse events (AEs), addressing gaps in age‐stratified risk assessment. Methods Disproportionality analysis (reporting odds ratios, RORs) and parametric Weibull
Guanghan Sun, Jingrong Yang, Lei Wan, Xia Xu, Jing Wang   +4 more
wiley   +1 more source

Biological aging, left ventricular dysfunction and mortality in patients with heart failure with preserved ejection fraction. [PDF]

NPJ Aging
Xu X, Huang Z, Xu X, Liu M, Huang R, Xiong Z, Guo Y, Zhang S, Zhou Z, Tang Z, Liao X, Zhuang X.   +11 more
europepmc   +1 more source

Virtual healthcare compared to hospital care for acute and post‐acute illness in adults: A systematic review and meta‐analysis of randomized controlled trials

British Journal of Clinical Pharmacology, EarlyView.
Aim To evaluate the clinical effectiveness, cost‐effectiveness, quality of life (QoL) and patient/caregiver satisfaction associated with VWs/HaH vs. traditional inpatient care in adults with acute or post‐acute illness. Methods We conducted a systematic review and meta‐analysis of randomized controlled trials (RCTs), following PRISMA 2020 guidelines ...
Rana A. Malhis, Stuart E. Bond, Ahmed A. Sadeq, Rani Shatnawi, Barbara R. Conway, Syed Shahzad Hasan, Mamoon A. Aldeyab   +6 more
wiley   +1 more source

Revascularization in Ischemic Left Ventricular Dysfunction: From Risk to Reality. [PDF]

J Soc Cardiovasc Angiogr Interv
Redfors B, Jha S, Omerovic E.
europepmc   +1 more source

Blood pressure effects of SGLT2 inhibitors and GLP‐1 receptor agonists: Mechanisms, trial evidence and Real‐world data

British Journal of Clinical Pharmacology, EarlyView.
SGLT2 inhibitors and GLP‐1 receptor agonists modestly lower blood pressure across diverse patient populations, including those without diabetes. These effects appear largely independent of glycaemic control and offer additive value in high‐risk patients with overlapping comorbidities.
Andrej Belančić, Yusuf Ziya Sener, Marijana Vučković, Joseph Edgar Blais, Almir Fajkić, Emina Sher, Mislav Radić, Josipa Radić   +7 more
wiley   +1 more source

Apixaban and Recurrent Stroke Risk With Left Ventricular Dysfunction: A Secondary Analysis of the ARCADIA Trial. [PDF]

Stroke
Sharma R, Jillella D, Zhang C, Elkind MSV, Kamel H, Di Tullio MR, Kronmal RA, Krishnaiah B, Yaghi S, Longstreth WT, Tirschwell DL, Merkler AE, Nahab F.   +12 more
europepmc   +1 more source

PREVALENCE OF LEFT VENTRICULAR DYSFUNCTION IN PATIENTS WITH COPD

Kashmala Shah,Majid Shah,Safa Shah,Brekhna Shah
openalex   +1 more source

An open‐label, single‐arm, dose‐escalating concentration–QT study to investigate the cardiac effects and safety of paroxetine in healthy adults

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aims Paroxetine is a selective serotonin reuptake inhibitor (SSRI), approved for treatment of major depressive disorder and anxiety disorders. Some SSRIs are known to prolong the QT interval; however, clinical evidence to establish a lack of association between paroxetine and corrected QT interval (QTc) prolongation is limited. Therefore, this
Sven C. van Dijkman, Mathieu Félices, Bhaskar Pandurangavittal, Sanman Ghorpade, Caroline Easterbrook, Marcin Zabielski, Oscar Della Pasqua   +6 more
wiley   +1 more source

Comparison of the correlation between triglyceride-glucose index and homeostasis model assessment of insulin resistance with subclinical left ventricular dysfunction. [PDF]

J Diabetes Investig
Zhou T, Wang X, Yan X, Guo W, Pi Z, Liang J, Gao Y, Zhang S, Hua M, Chen C, Zhao X, Liu M.   +11 more
europepmc   +1 more source